The treatment of human cancer cells with TAT-IL-24-KDEL and YM155 resulted in a synergistic phosphorylation of JNK and c-Jun, activation of PARP, and an increase in caspase-3/7 activity (Figure 7C and 7D). Here, CASP3 is linked to cancer.